Mutual of America Capital Management LLC bought a new stake in shares of Iqvia Holdings Inc (NYSE:IQV) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 19,659 shares of the medical research company’s stock, valued at approximately $1,925,000.
Other large investors have also bought and sold shares of the company. Franklin Street Advisors Inc. NC acquired a new stake in shares of Iqvia during the 4th quarter valued at about $7,446,000. Chevy Chase Trust Holdings Inc. acquired a new stake in shares of Iqvia during the 4th quarter valued at about $14,462,000. Bremer Trust National Association acquired a new stake in shares of Iqvia during the 4th quarter valued at about $1,445,000. Nisa Investment Advisors LLC acquired a new stake in shares of Iqvia during the 4th quarter valued at about $920,000. Finally, IFM Investors Pty Ltd acquired a new stake in shares of Iqvia during the 4th quarter valued at about $575,000. Hedge funds and other institutional investors own 95.91% of the company’s stock.
Shares of Iqvia Holdings Inc (NYSE:IQV) opened at $100.06 on Wednesday. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 1.29. Iqvia Holdings Inc has a twelve month low of $75.94 and a twelve month high of $110.67. The stock has a market capitalization of $20,513.85, a PE ratio of 22.52, a P/E/G ratio of 1.34 and a beta of 0.61.
In other Iqvia news, major shareholder Cpp Investment Board Private H sold 7,497,807 shares of the firm’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $102.00, for a total value of $764,776,314.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director John Connaughton sold 1,163,191 shares of the firm’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $102.00, for a total transaction of $118,645,482.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 8,727,078 shares of company stock worth $890,124,079. 6.40% of the stock is currently owned by insiders.
A number of equities research analysts have recently commented on IQV shares. Mitsubishi UFJ Financial Group started coverage on Iqvia in a research report on Friday, December 15th. They set a “neutral” rating and a $112.00 target price on the stock. KeyCorp reiterated a “sector weight” rating and issued a $100.00 price objective on shares of Iqvia in a report on Friday, November 10th. Morgan Stanley lifted their price objective on Iqvia from $96.00 to $121.00 and gave the stock an “overweight” rating in a report on Thursday, November 9th. Barclays lifted their price objective on Iqvia from $100.00 to $120.00 and gave the stock an “overweight” rating in a report on Friday, October 27th. Finally, Zacks Investment Research upgraded Iqvia from a “hold” rating to a “buy” rating and set a $121.00 price objective on the stock in a report on Tuesday, October 31st. Seven analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $109.71.
COPYRIGHT VIOLATION NOTICE: “Mutual of America Capital Management LLC Takes $1.93 Million Position in Iqvia Holdings Inc (IQV)” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/14/mutual-of-america-capital-management-llc-takes-1-93-million-position-in-iqvia-holdings-inc-iqv.html.
IQVIA Holdings Inc, formerly Quintiles IMS Holdings, Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.